Results 21 to 30 of about 1,816,514 (190)

Transcatheter Tricuspid Valve Intervention: Coaptation Devices [PDF]

Frontiers in Cardiovascular Medicine, 2020
Transcatheter tricuspid valve intervention (TTVI) has recently emerged as an alternative for the treatment of severe tricuspid regurgitation (TR). Multiple percutaneous devices have been developed in the last decade with promising early results.
Guillem Muntané-Carol, Alberto Alperi, Laurent Faroux, Elisabeth Bédard, François Philippon, Josep Rodés-Cabau   +5 more
openaire   +3 more sources

The Current Landscape of Transcatheter Tricuspid Valve Intervention

Journal of the Society for Cardiovascular Angiography & Interventions, 2023
Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%.
Henry Seligman, Amit N. Vora, Noah Q. Haroian, Rishi Puri, Ee Ling Heng, Robert D. Smith, Azeem Latib, Raj Makkar, Paul Sorajja, Martin B. Leon, Yousif Ahmad   +10 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Intervention: Current Perspective

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects. Historically, therapeutic options for TR were limited to surgical approaches, which are often complicated by significant morbidity and mortality in elderly patients with multiple ...
Trevor J Simard, Mackram F Eleid
openaire   +3 more sources

4-Year Follow-Up after Transatrial Transcatheter Tricuspid Valve Replacement with the LuX-Valve

Journal of Cardiovascular Development and Disease, 2022
Tricuspid regurgitation (TR) has become one of the most common valve diseases. Patients with severe TR are often at high surgical mortality risk. Transcatheter tricuspid valve interventions have emerged as a promising alternative to open-heart surgery ...
Xiaoping Ning, Jingyi Cao, Wei Wang, Guangwei Zhou, Fan Yang, Zhiyun Xu, Lin Han, Fan Qiao, Fanglin Lu   +8 more
doaj   +1 more source

Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up

Frontiers in Cardiovascular Medicine, 2023
Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary ...
Abdurashid Mussayev, Serik Alimbayev, Nursultan Tanaliev, Aidyn Kuanyshbek, Aripov Marat, Timur Lesbekov, Yerkezhan Raissov, Aigerim Sadykova, Askarovna Kenzhebayeva Kamila, Murat Mukarov, Yuriy Pya   +10 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

The current state of isolated tricuspid valve surgery: how it complements transcatheter tricuspid valve interventions. [PDF]

ASVIDE
Ricky Patil, Matthew Kazaleh, Gorav Ailawadi   +2 more
openaire   +2 more sources

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis. [PDF]

, 2021
OBJECTIVES The aims of this study were to document the prevalence of concomitant tricuspid regurgitation (TR) before and after transcatheter aortic valve replacement (TAVR), to quantify potential eligibility for transcatheter tricuspid valve ...
Heg, Dik, Lanz, Jonas, Windecker, Stephan, Tomii, Daijiro, Praz, Fabien, Reineke, David, Pilgrim, Thomas, Okuno, Taishi, Stortecky, Stefan, Wild, Mirjam Gauri   +9 more
core   +4 more sources

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J, Reinthaler, M, Georg M Fröhlich, Marco Roffi, Olaf Wendler, Nevil Hutchinson, Markus Reinthaler, Duolao Wang, David Hildick-Smith, Wang, D, Hutchinson, N, Fröhlich, GM, John Webb, Pascal Meier, Alexandra J Lansky, Wendler, O, Hildick-Smith, D, Stefan Toggweiler, Lansky, AJ, Roffi, M, Meier, P, Toggweiler, S   +21 more
core   +2 more sources